Systemic Effects of Repeated Intraocular Dexamethasone Intravitreal Implant in Diabetic Patients: A Retrospective Study.
Alicia Valverde-MegíasPilar Cifuentes-CanoreaJorge Ruiz-MedranoPablo Peña-GarcíaAlicia Megías-FresnoJuan Donate-LópezJulián García-FeijooPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2017)
Ozurdex injections had no influence on HbA1c or renal function. Lipid profile changes were mild and transient. However, a significant temporary increase has been found in LDL cholesterol levels in patients receiving simultaneous bilateral injections. Lipid levels should be monitored in patients starting with bilateral Ozurdex injections especially in those with recent history of acute myocardial infarction.
Keyphrases
- acute myocardial infarction
- end stage renal disease
- platelet rich plasma
- ultrasound guided
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- high dose
- case report
- percutaneous coronary intervention
- heart failure
- diabetic retinopathy
- fatty acid
- cerebral ischemia
- brain injury
- blood brain barrier
- soft tissue
- drug induced